AU2003252660A1 - Tocolytic agent comprising ep2 agonist as the active ingredient - Google Patents

Tocolytic agent comprising ep2 agonist as the active ingredient

Info

Publication number: AU2003252660A1
Authority: AU; Australia
Prior art keywords: agonist; active ingredient; tocolytic agent; tocolytic; agent
Prior art date: 2002-07-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003252660A

Inventor

Hiroyuki Harada

Takaaki Obata

Tsutomu Shiroya

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ono Pharmaceutical Co Ltd

Original Assignee

Ono Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-18

Filing date

2003-07-17

Publication date

2004-02-09

2003-07-17 Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd

2004-02-09 Publication of AU2003252660A1 publication Critical patent/AU2003252660A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003252660A 2002-07-18 2003-07-17 Tocolytic agent comprising ep2 agonist as the active ingredient Abandoned AU2003252660A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002210290A JP2006021998A (en)	2002-07-18	2002-07-18	Dysmenorrhea-treating agent containing ep2 agonist as active ingredient
JP2002-210290		2002-07-18
PCT/JP2003/009091 WO2004009117A1 (en)	2002-07-18	2003-07-17	Tocolytic agent comprising ep2 agonist as the active ingredient

Publications (1)

Publication Number	Publication Date
AU2003252660A1 true AU2003252660A1 (en)	2004-02-09

Family

ID=30767720

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003252660A Abandoned AU2003252660A1 (en)	2002-07-18	2003-07-17	Tocolytic agent comprising ep2 agonist as the active ingredient

Country Status (3)

Country	Link
JP (1)	JP2006021998A (en)
AU (1)	AU2003252660A1 (en)
WO (1)	WO2004009117A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8183286B2 (en)	2006-11-16	2012-05-22	Gemmus Pharma Inc.	EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
EP2149554A1 (en)	2008-07-30	2010-02-03	Bayer Schering Pharma Aktiengesellschaft	Indolyamides as modulators for an EP2 receptor
EP2149551A1 (en)	2008-07-30	2010-02-03	Bayer Schering Pharma AG	N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors
EP2149552A1 (en)	2008-07-30	2010-02-03	Bayer Schering Pharma AG	5,6 substituted benzamide derivatives as modulators of EP2 receptors
GB2597731A (en) *	2020-07-31	2022-02-09	Imperial College Innovations Ltd	Preterm labour

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5462968A (en) *	1994-01-19	1995-10-31	Allergan, Inc.	EP2 -receptor agonists as agents for lowering intraocular pressure
US5698598A (en) *	1995-08-04	1997-12-16	Allergan	EP2 -receptor agonists as agents for lowering intraocular pressure
UA59384C2 (en) *	1996-12-20	2003-09-15	Пфайзер, Інк.	Preventing bone mass loss and recovery thereof by means of prostaglandin agonists
NO317155B1 (en) *	1997-02-04	2004-08-30	Ono Pharmaceutical Co	<Omega> -cycloalkyl-prostaglandin-E <N> 2 </ N> derivatives
US6531485B2 (en) *	1997-06-23	2003-03-11	Pfizer Inc.	Prostaglandin agonists
UA67754C2 (en) *	1997-10-10	2004-07-15	Пфайзер, Інк.	Prostaglandin agonists and use thereof for the treatment of bone disorders
US6124314A (en) *	1997-10-10	2000-09-26	Pfizer Inc.	Osteoporosis compounds
EP1042283B1 (en) *	1997-12-25	2004-02-25	Ono Pharmaceutical Co., Ltd.	Omega-cycloalkyl-prostaglandin e2 derivatives
US6235780B1 (en) *	1998-07-21	2001-05-22	Ono Pharmaceutical Co., Ltd.	ω-cycloalkyl-prostaglandin E1 derivatives
US6376533B1 (en) *	2000-10-20	2002-04-23	Allergan Sales, Inc.	Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists

2002
- 2002-07-18 JP JP2002210290A patent/JP2006021998A/en active Pending
2003
- 2003-07-17 WO PCT/JP2003/009091 patent/WO2004009117A1/en not_active Ceased
- 2003-07-17 AU AU2003252660A patent/AU2003252660A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004009117A1 (en)	2004-01-29
JP2006021998A (en)	2006-01-26

Publication	Publication Date	Title
AU2003255845A1 (en)	2004-03-11	Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
AU2003280269A1 (en)	2004-06-18	Device for automatically injecting an active substance
AU2002253188A1 (en)	2003-10-27	Active substance evaporator
AU2003238179A1 (en)	2003-12-22	Herbicidally active heterocyclylalkynes
AU2003232851A1 (en)	2004-01-06	Fungicidal combinations of active substances
PL374390A1 (en)	2005-10-17	Fungicidal active substance combinations
AU2003267255A1 (en)	2004-04-08	Methods and devices for active bioassay
EP1717246B8 (en)	2015-10-07	Tnf antagonists and tnf inhibitors comprising the same as the active ingredient
AU2002333394A1 (en)	2003-06-05	Fungicide active substance combinations
AU2002364468A1 (en)	2003-09-18	Solid orally-dispersible pharmaceutical formulation
AU2003226487A1 (en)	2003-09-22	Formulation
AU2003228236A1 (en)	2003-09-16	Dynamic time metered delivery
AU2003213997A1 (en)	2003-09-16	Biologically active copper-organic agents
IL166730A0 (en)	2006-01-15	N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-Ä1,3,4-oxadiazol-2-ylÜphenyl)pyridine-3-sulphonamide as an anticancer agent
AU2003227186A1 (en)	2003-10-08	Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
AU2003252660A1 (en)	2004-02-09	Tocolytic agent comprising ep2 agonist as the active ingredient
AU2003259532A1 (en)	2005-02-14	Ready-to-drink formulation containing an active ingredient
AU2003291642A1 (en)	2004-06-18	Pyrazoloazepine compounds as pharmaceutical agents
AU2003207181A1 (en)	2003-09-02	Microorganism-trapping agent
IL160944A0 (en)	2004-08-31	Neurotensin active 2,3-diaryl-pyrazolidine derivatives
WO2004051549A8 (en)	2005-03-17	Active agent delivery method
AU2003240741A1 (en)	2003-12-31	Calixarenes for use as excipient for an active substance
AU2003228305A1 (en)	2003-10-13	Pharmaceutical composition with combined active agents and methods for using the same
AU2003282633A1 (en)	2004-06-15	Preservative agent
AU2003244257A1 (en)	2004-02-25	Injectable composition comprising florfenicol as an active ingredient

Legal Events

Date	Code	Title	Description
2005-04-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase